JP2015500813A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500813A5 JP2015500813A5 JP2014545042A JP2014545042A JP2015500813A5 JP 2015500813 A5 JP2015500813 A5 JP 2015500813A5 JP 2014545042 A JP2014545042 A JP 2014545042A JP 2014545042 A JP2014545042 A JP 2014545042A JP 2015500813 A5 JP2015500813 A5 JP 2015500813A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- growth hormone
- peptide
- composition according
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 102000018997 Growth Hormone Human genes 0.000 claims 10
- 108010051696 Growth Hormone Proteins 0.000 claims 10
- 239000000122 growth hormone Substances 0.000 claims 10
- 150000001413 amino acids Chemical class 0.000 claims 4
- 210000000845 Cartilage Anatomy 0.000 claims 3
- 102000002265 Human Growth Hormone Human genes 0.000 claims 3
- 108010000521 Human Growth Hormone Proteins 0.000 claims 3
- 239000000854 Human Growth Hormone Substances 0.000 claims 3
- 102000004218 Insulin-like growth factor I Human genes 0.000 claims 3
- 108090000723 Insulin-like growth factor I Proteins 0.000 claims 3
- 210000003205 Muscles Anatomy 0.000 claims 3
- 208000002193 Pain Diseases 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 230000036407 pain Effects 0.000 claims 3
- 206010022114 Injury Diseases 0.000 claims 2
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 2
- 230000000875 corresponding Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- 206010008479 Chest pain Diseases 0.000 claims 1
- 206010008685 Chondritis Diseases 0.000 claims 1
- 210000001612 Chondrocytes Anatomy 0.000 claims 1
- 210000002808 Connective Tissue Anatomy 0.000 claims 1
- 206010061428 Decreased appetite Diseases 0.000 claims 1
- 210000002351 Embryonic Muscle Cell Anatomy 0.000 claims 1
- 210000004905 Finger nails Anatomy 0.000 claims 1
- 206010061205 Hereditary disease Diseases 0.000 claims 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 claims 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 claims 1
- 238000008214 LDL Cholesterol Methods 0.000 claims 1
- 210000003041 Ligaments Anatomy 0.000 claims 1
- 208000005264 Motor Neuron Disease Diseases 0.000 claims 1
- 206010028003 Motor neurone disease Diseases 0.000 claims 1
- 206010028289 Muscle atrophy Diseases 0.000 claims 1
- 208000003627 Muscular Dystrophy Diseases 0.000 claims 1
- 208000004296 Neuralgia Diseases 0.000 claims 1
- 208000006883 Neuromuscular Disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000005877 Painful Neuropathy Diseases 0.000 claims 1
- 208000001076 Sarcopenia Diseases 0.000 claims 1
- 210000002435 Tendons Anatomy 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000003698 anagen phase Effects 0.000 claims 1
- 230000036592 analgesia Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000004027 cells Anatomy 0.000 claims 1
- 230000037319 collagen production Effects 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 230000003779 hair growth Effects 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 238000011133 mesenchymal stem cell therapy Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000020763 muscle atrophy Effects 0.000 claims 1
- 230000003387 muscular Effects 0.000 claims 1
- 201000000585 muscular atrophy Diseases 0.000 claims 1
- 201000006938 muscular dystrophy Diseases 0.000 claims 1
- 201000002481 myositis Diseases 0.000 claims 1
- 201000009384 neuromuscular junction disease Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 201000008125 pain agnosia Diseases 0.000 claims 1
- 230000001575 pathological Effects 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 1
- 238000009168 stem cell therapy Methods 0.000 claims 1
- 238000009580 stem-cell therapy Methods 0.000 claims 1
- 201000010874 syndrome Diseases 0.000 claims 1
- 230000000472 traumatic Effects 0.000 claims 1
Claims (13)
- (a)変形性関節症の処置、
(b)成長ホルモン投与が有益である病態の処置であって、該病態は、筋肉の障害、消耗性障害、悪液質、食欲不振、エイズ消耗性症候群、HIVおよび他のウイルスによる消耗症、HIV、筋ジストロフィー、神経筋疾患、運動ニューロン疾患、神経筋接合部の疾患、炎症性ミオパシー、熱傷、傷害、感染もしくは外傷、LDLコレステロールの上昇を伴う病態から選択される処置、または鎮痛の緩和のための処置、
(c)疼痛の処置、
(d)軟骨細胞、プロテオグリカン、もしくはコラーゲンの産生、質、もしくは修復の増加または軟骨組織の形成もしくは修復の促進、
(e)筋肉、靱帯、または腱の量、修復、形態、または機能の促進または向上、
(f)指の爪および毛髪の成長の増進、あるいは
(g)筋肉または結合組織の炎症性、外傷性、または遺伝性の疾患の処置
のための医薬組成物であって、
成長ホルモンのカルボキシル末端配列を含んでなるが、IGF−1産生に関与する成長ホルモンのドメインを含まないペプチドを含み、
ここで、前記病態は肥満症ではない、医薬組成物。 - 前記病態が虚弱またはサルコペニアである、請求項1に記載の医薬組成物。
- 前記疼痛が、有痛性ニューロパシーおよび神経因性疼痛、肋軟骨炎に起因する胸痛、椎間板ヘルニアに起因する背痛、ならびに筋萎縮に伴う疼痛から選択される、請求項1に記載の医薬組成物。
- 前記ペプチドが筋芽細胞への分化を促進する、請求項1に記載の医薬組成物。
- 機能軟骨細胞の不足または機能軟骨組織の不足を伴う病態の処置のための、成長ホルモンのカルボキシル末端配列を含んでなるが、成長ホルモンのIGF−1ドメインを含まないペプチドを含んでなる、医薬組成物。
- 前記ペプチドがヒト成長ホルモンのカルボキシル末端配列または非ヒト動物の成長ホルモンのカルボキシル末端配列を含んでなる、請求項1〜5のいずれか一項に記載の医薬組成物。
- 前記ペプチドが間葉系幹細胞療法と組み合わせて投与されるものである、請求項1に記載の医薬組成物。
- 関節および筋肉の修復のための幹細胞療法を補うための、成長ホルモンのカルボキシル末端配列を含んでなるが、IGF−1産生に関与する成長ホルモンのドメインを含まないペプチドを含む、医薬組成物。
- 前記ペプチドがヒト成長ホルモンのアミノ酸182〜189または別の動物由来の成長ホルモンの対応するアミノ酸を含んでなる、請求項1〜8のいずれか一項に記載の医薬組成物。
- 前記ペプチドがヒト成長ホルモンのアミノ酸177〜191または別の動物由来の成長ホルモンの対応するアミノ酸を含んでなる、請求項9に記載の医薬組成物。
- 前記ペプチドが、配列番号1〜41から選択される配列を含んでなる、請求項9に記載の医薬組成物。
- 前記ペプチドが、配列番号1〜41から選択される配列から本質的になる、請求項9に記載の医薬組成物。
- 前記ペプチドが関節内投与によりヒアルロン酸とともに提供される、請求項1に記載の変形性関節症の処置のための医薬組成物。
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011905132A AU2011905132A0 (en) | 2011-12-09 | Use of growth hormone fragments | |
AU2011905132 | 2011-12-09 | ||
AU2011905133A AU2011905133A0 (en) | 2011-12-09 | Use of growth hormone fragments | |
AU2011905133 | 2011-12-09 | ||
AU2012901398 | 2012-04-10 | ||
AU2012901400 | 2012-04-10 | ||
AU2012901398A AU2012901398A0 (en) | 2012-04-10 | Use of growth hormone fragments | |
AU2012901400A AU2012901400A0 (en) | 2012-04-10 | Use of growth hormone fragments | |
PCT/AU2012/001497 WO2013082667A1 (en) | 2011-12-09 | 2012-12-07 | Use of growth hormone fragments |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018055232A Division JP6786544B2 (ja) | 2011-12-09 | 2018-03-22 | 成長ホルモン断片の使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015500813A JP2015500813A (ja) | 2015-01-08 |
JP2015500813A5 true JP2015500813A5 (ja) | 2016-01-14 |
JP6363952B2 JP6363952B2 (ja) | 2018-07-25 |
Family
ID=48573423
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014545042A Active JP6363952B2 (ja) | 2011-12-09 | 2012-12-07 | 成長ホルモン断片の使用 |
JP2018055232A Active JP6786544B2 (ja) | 2011-12-09 | 2018-03-22 | 成長ホルモン断片の使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018055232A Active JP6786544B2 (ja) | 2011-12-09 | 2018-03-22 | 成長ホルモン断片の使用 |
Country Status (12)
Country | Link |
---|---|
US (2) | US10111933B2 (ja) |
EP (1) | EP2788014B8 (ja) |
JP (2) | JP6363952B2 (ja) |
KR (2) | KR102148910B1 (ja) |
CN (2) | CN103987402B (ja) |
AU (1) | AU2012327167B2 (ja) |
BR (1) | BR112014013757A2 (ja) |
CA (1) | CA2857686C (ja) |
DK (1) | DK2788014T3 (ja) |
ES (1) | ES2764106T3 (ja) |
RU (1) | RU2639474C2 (ja) |
WO (1) | WO2013082667A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2788014T3 (da) * | 2011-12-09 | 2020-01-02 | Metabolic Pharmaceuticals Pty Ltd | Anvendelse af væksthormonfragmenter |
RU2020123165A (ru) | 2018-01-15 | 2022-02-17 | Лэйтерал Ип Пти Лтд | Пептиды и их применение |
CA3142185A1 (en) * | 2019-05-31 | 2020-12-03 | Lateral IP Pty Ltd | Peptides and uses thereof |
KR102507333B1 (ko) | 2019-12-12 | 2023-03-07 | 조선대학교산학협력단 | 악테오사이드를 포함하는 약학적 조성물 및 건강기능식품 |
EP4081237A4 (en) * | 2019-12-27 | 2024-01-17 | Lateral Ip Pty Ltd | CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-TYPE PROTEIN (LANCL) AND USES THEREOF |
CA3171917A1 (en) * | 2020-03-16 | 2021-09-23 | Andrew GEARING | Compositions for treating respiratory tract infection and uses thereof |
AU2022269043A1 (en) * | 2021-05-07 | 2023-11-30 | Lateral Pharma Pty Ltd | Compositions for treating inflammatory airway disease and uses thereof |
CN114380902B (zh) * | 2021-12-29 | 2023-06-16 | 江苏诺泰澳赛诺生物制药股份有限公司 | 一种hgh(176-191)的制备方法 |
CN116333091A (zh) * | 2023-03-31 | 2023-06-27 | 江苏诺泰澳赛诺生物制药股份有限公司 | 连续流固相合成制备hgh(176-191)的方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU693478B2 (en) | 1994-11-10 | 1998-07-02 | Metabolic Pharmaceuticals Limited | Treatment of obesity |
WO1999012969A1 (en) * | 1997-09-08 | 1999-03-18 | Metabolic Pharmaceuticals Ltd. | Treatment of obesity |
AUPQ387599A0 (en) * | 1999-11-05 | 1999-12-02 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
WO2002016551A2 (en) | 2000-08-18 | 2002-02-28 | University Of Massachusetts Medical Center | Trance regulation of chondrocyte differentiation |
AUPQ981700A0 (en) * | 2000-09-01 | 2000-09-28 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
EP1501539A1 (en) | 2002-05-03 | 2005-02-02 | Metabolic Pharmaceuticals Ltd. | Method for control of depression using c terminal growth hormone (gh) fragment |
US20040142870A1 (en) * | 2002-11-20 | 2004-07-22 | Finn Rory F. | N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
ZA200509864B (en) * | 2003-05-09 | 2008-02-27 | Neose Technologies Inc | Compositions and methods for the preparation of human growth hormone glycosylation mutants |
CN1838966A (zh) | 2003-07-29 | 2006-09-27 | 阿雷斯贸易股份有限公司 | 人生长激素在多系统萎缩症中的用途 |
JP4511470B2 (ja) | 2003-10-29 | 2010-07-28 | 帝人株式会社 | ヒアルロン酸化合物、そのハイドロゲルおよび関節軟骨損傷治療用材料 |
JP2007530543A (ja) | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス,インコーポレイテッド | 間葉幹細胞及びその使用法 |
WO2005105132A1 (en) * | 2004-05-04 | 2005-11-10 | Metabolic Pharmaceuticals Limited | Methods for preventing or treating bone disorders |
CA2574791A1 (en) * | 2004-07-20 | 2006-02-09 | Genentech, Inc. | Compositions and methods of using angiopoietin-like 4 protein |
US7998930B2 (en) * | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
JP4388483B2 (ja) | 2004-12-27 | 2009-12-24 | 株式会社ツーセル | 間葉系幹細胞の骨化及び/又は軟骨化促進剤と骨化及び/又は軟骨化促進方法 |
WO2006133477A1 (en) * | 2005-06-14 | 2006-12-21 | Metabolic Pharmaceuticals Limited | Peptides corresponding to human growth hormone |
JP2009506096A (ja) * | 2005-08-30 | 2009-02-12 | ノボ ノルディスク ヘルス ケア アーゲー | ペグ化成長ホルモンの液状調製物 |
WO2007068039A1 (en) * | 2005-12-12 | 2007-06-21 | Metabolic Pharmaceuticals Limited | Treatment of weight gain in estrogen deficient mammals |
ES2875426T3 (es) | 2008-04-29 | 2021-11-10 | Ascendis Pharma Endocrinology Div A/S | Compuestos de hormona de crecimiento humana recombinante pegilada |
JP2011525800A (ja) * | 2008-06-27 | 2011-09-29 | ノボ ノルディスク ヘルス ケア アーゲー | 長時間にわたる循環半減期を有するn−グリコシル化ヒト成長ホルモン |
US20110263501A1 (en) * | 2008-09-09 | 2011-10-27 | Nono Nordisk Health Care AG | Growth Hormone Conjugate with Increased Stability |
US20100197590A1 (en) * | 2009-02-03 | 2010-08-05 | Pfizer Inc | 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES |
WO2011038205A2 (en) | 2009-09-25 | 2011-03-31 | Curna, Inc. | Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh |
CN102190721A (zh) * | 2010-03-03 | 2011-09-21 | 北京双鹭药业股份有限公司 | 一种长效生长激素 |
DK2788014T3 (da) * | 2011-12-09 | 2020-01-02 | Metabolic Pharmaceuticals Pty Ltd | Anvendelse af væksthormonfragmenter |
-
2012
- 2012-12-07 DK DK12855593.5T patent/DK2788014T3/da active
- 2012-12-07 KR KR1020197033998A patent/KR102148910B1/ko active IP Right Grant
- 2012-12-07 KR KR1020147017931A patent/KR20140101397A/ko active Application Filing
- 2012-12-07 WO PCT/AU2012/001497 patent/WO2013082667A1/en active Application Filing
- 2012-12-07 CN CN201280060658.0A patent/CN103987402B/zh active Active
- 2012-12-07 ES ES12855593T patent/ES2764106T3/es active Active
- 2012-12-07 CA CA2857686A patent/CA2857686C/en active Active
- 2012-12-07 BR BR112014013757A patent/BR112014013757A2/pt active Search and Examination
- 2012-12-07 JP JP2014545042A patent/JP6363952B2/ja active Active
- 2012-12-07 EP EP12855593.5A patent/EP2788014B8/en active Active
- 2012-12-07 RU RU2014124030A patent/RU2639474C2/ru active
- 2012-12-07 US US14/363,256 patent/US10111933B2/en active Active
- 2012-12-07 CN CN201910445102.7A patent/CN110448683A/zh active Pending
- 2012-12-07 AU AU2012327167A patent/AU2012327167B2/en active Active
-
2018
- 2018-03-22 JP JP2018055232A patent/JP6786544B2/ja active Active
- 2018-09-19 US US16/136,167 patent/US10758593B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015500813A5 (ja) | ||
Haugen et al. | Injectable biomaterials for dental tissue regeneration | |
TWI480069B (zh) | 用以改善心肌梗塞之醫藥組成物 | |
Bartold et al. | Mesenchymal stem cells and biologic factors leading to bone formation | |
RU2014124030A (ru) | Применение фрагментов гормона роста | |
Prieto et al. | Biomimetic calcium phosphate mineralization with multifunctional elastin-like recombinamers | |
He et al. | Polyzwitterion manipulates remineralization and antibiofilm functions against dental demineralization | |
Hu et al. | Chitosan-based biomimetically mineralized composite materials in human hard tissue repair | |
Li et al. | Strontium ranelate incorporated enzyme-cross-linked gelatin nanoparticle/silk fibroin aerogel for osteogenesis in OVX-induced osteoporosis | |
RU2020123165A (ru) | Пептиды и их применение | |
WO2007022537A2 (en) | Use of lactoferrin as a chemokine and a chemotactic modulator | |
Liu et al. | Research on graphene and its derivatives in oral disease treatment | |
JP2016153396A (ja) | 歯周組織再生剤、歯周組織再生方法、歯周組織増殖・活性化剤及び歯周組織アンチエージング剤 | |
Dervan et al. | Biomaterial and therapeutic approaches for the manipulation of macrophage phenotype in peripheral and central nerve repair | |
Fu et al. | MXene-functionalized ferroelectric nanocomposite membranes with modulating surface potential enhance bone regeneration | |
KR20120014251A (ko) | 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법 | |
Chen et al. | Hydrogels for oral tissue engineering: challenges and opportunities | |
RU2015153242A (ru) | Действующее вещество для лечения саркопении | |
WO2010071217A1 (ja) | 抗歯周病菌剤及びそれを用いた医療用または歯科用材料 | |
CA et al. | Mesenchymal stem cells seeded decellularized tendon scaffold for tissue engineering | |
JP6648142B2 (ja) | グリコサミノグリカンおよびタンパク質を含む組成物 | |
JP2021155335A (ja) | 変形性関節症の処置および/または予防方法 | |
JP6165449B2 (ja) | 発酵乳食品 | |
CN101991513A (zh) | 用于个人护理的化妆品和药品的生产原料 | |
Batra et al. | Trend of nanofibers in dental regeneration: perspectives and challenges |